SNORD88C acts as a non-invasive diagnostic biomarker for non-small cell lung cancer (NSCLC), promoting cancer progression by enhancing SCD1 translation through specific RNA modifications, which leads to inhibited autophagy and increased tumour growth and metastasis [60]. Here, SNORD88C is linked to non-small cell lung carcinoma.